Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Julia L. Ziegengeist
Observed name:
Julia Lea Ziegengeist
Institution:
Levine Cancer Institute
Observed institution:
Levine Cancer Institute
ORCID:
0009-0006-3878-7242
Observed ORCID:
0009-0006-3878-7242
OpenAlex ID:
A5047963528
Alpelisib-Induced Diabetic Ketoacidosis: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and Review of the Literature
2024
·
Julia L. Ziegengeist
, Joseph B. Elmes
, et al.
·
Clinical Breast Cancer
·
11
A Clinical Review of Subcutaneous Trastuzumab and the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer
2024
·
Julia L. Ziegengeist
, Antoinette R. Tan
·
Clinical Breast Cancer
·
6
Inflation Reduction Act Impact on the Hematology/Oncology Treatment Landscape
2026
·
Mei Ka Fong
, Grace Elsey
, et al.
·
The American Journal of Managed Care
Show more works
View as search
Works count:
3
Citation count:
17
H-index:
2
I10-index:
1
Year
Topic
Type